Amneal Pharmaceuticals Launches Focinvez, Ready-To-Use Injectable Anti-Nausea Agent For Chemotherapy; Second Injectable RTU Product Launched In 2024; Single-Dose Vial Free Of Polysorbate 80, No Reconstitution Required
Amneal Pharmaceuticals Launches Focinvez, Ready-To-Use Injectable Anti-Nausea Agent For Chemotherapy; Second Injectable RTU Product Launched In 2024; Single-Dose Vial Free Of Polysorbate 80, No Reconstitution Required
Amneal pharmaceuticals推出Focinvez，一種用於化療的即用型注射型抗噁心劑；2024年推出的第二個即用型注射劑；單次劑量小瓶不含聚山梨酯80，無需重新配置
Amneal Pharmaceuticals Launches Focinvez, Ready-To-Use Injectable Anti-Nausea Agent For Chemotherapy; Second Injectable RTU Product Launched In 2024; Single-Dose Vial Free Of Polysorbate 80, No Reconstitution Required
Amneal pharmaceuticals推出Focinvez，一種用於化療的即用型注射型抗噁心劑；2024年推出的第二個即用型注射劑；單次劑量小瓶不含聚山梨酯80，無需重新配置
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。